Xatral 5mg Tablets is a medication that belongs to the class of alpha-1 adrenergic antagonists. Its primary mechanism of action involves selectively blocking alpha-1 adrenergic receptors located in the smooth muscle of the prostate and bladder neck. By inhibiting these receptors, Xatral causes relaxation of the smooth muscle, which alleviates the obstruction of urinary flow caused by benign prostatic hyperplasia (BPH). This relaxation facilitates easier urination and reduces associated symptoms such as urgency, frequency, and the sensation of incomplete bladder emptying. Additionally, the drug's mechanism may contribute to decreased nocturnal urination, enhancing overall urinary function and comfort for patients.
Indications and Uses of Xatral 5mg Tablets
- Management of symptoms associated with benign prostatic hyperplasia (BPH)
- Facilitation of urination in patients with urinary flow obstruction due to BPH
Side Effects of Xatral 5mg Tablets
- Dizziness or lightheadedness
- Fatigue
- Headache
- Nausea
- Hypotension (low blood pressure)
- Palpitations
- Nasopharyngitis
- Sexual dysfunction
Storage and Handling
Store Xatral 5mg Tablets at room temperature, away from moisture and heat. Keep the medication out of reach of children and do not use it after the expiration date printed on the package.
Patient Advice and Precautions
It is advisable to take Xatral after meals to enhance absorption and minimize gastrointestinal side effects. Patients should be counseled on the potential for dizziness, especially when standing up quickly, to prevent falls. Regular follow-up with a healthcare provider is essential for monitoring the effectiveness and tolerability of the treatment. Patients should inform their doctor of any other medications they are taking to avoid possible interactions.
Scientific Degree: pharmacist
Country: Egypt
Clinical Pharmacist | Medical & Pharmaceutical Content Writer & Reviewer
A licensed Egyptian pharmacist registered with the Egyptian Pharmacists Syndicate, holding a Bachelor of Pharmaceutical Sciences (B.Pharm.) from the Faculty of Pharmacy, Cairo University in Pharmaceutical Chemistry. She possesses extensive hands-on experience in community pharmacy practice and clinical patient education, specializing in pharmacokinetics, drug-drug interactions, and evidence-based dosing guidelines for both adults and pediatrics.
Dr. Nada serves as a medical writer and reviewer at Rosheta, dedicated to simplifying complex pharmacological data for patients while delivering accurate, up-to-date clinical insights rooted in approved prescribing information and official regulatory standards, including the Egyptian Drug Authority (EDA) and the U.S. FDA.
Published Date: 04 September 2024
you should ask your doctor before taking this medicine